FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for the treatment of acute ulcerative gastroduodenal bleeding. Complex of haemostatic measures is performed with the appointment of a fibrinolysis inhibitor drug. In this case, the preparation of aminomethylbenzoic acid is used as an inhibitor of fibrinolysis intramuscularly or intravenously in doses of 50–100 mg (5–10 ml of a solution of 10 mg/ml). Method makes it possible to achieve a stable haemostatic effect.
EFFECT: invention is intended for the treatment of acute ulcerative gastroduodenal bleeding.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD TO STOP GASTRODUODENAL BLEEDING | 2015 |
|
RU2618406C1 |
METHOD FOR ENDOSCOPIC STOP OF GASTROINTESTINAL BLEEDING | 2016 |
|
RU2632771C1 |
METHOD FOR ENDOSCOPIC TREATMENT OF ULCEROUS GASTRODUODENAL BLEEDING | 2015 |
|
RU2633588C2 |
METHOD FOR TREATMENT OF TEAR-HEMORRHAGIC SYNDROME (MALLORY-WEISS ESOPHAGEAL TEAR) | 2016 |
|
RU2633925C2 |
METHOD FOR ENDOSCOPIC HEMOSTASIS OF BLEEDING GASTRODUODENAL ULCER | 2021 |
|
RU2762120C1 |
METHOD OF ENDOSCOPIC HEMOSTASIS IN ULCER GASTRODUODENAL HEMORRHAGES | 2017 |
|
RU2675996C1 |
METHOD OF HEMOSTASIS IN HEMORRHAGIC GASTRITIS | 1991 |
|
RU2006225C1 |
METHOD OF CARRYING OUT ENDOSCOPIC HEMOSTASIS IN CASE OF ACUTE GASTRODUODENAL HEMORRHAGE | 2009 |
|
RU2398535C1 |
METHOD FOR ENDOSCOPIC TREATMENT OF MALLORY-WEISS SYNDROME | 2021 |
|
RU2762121C1 |
METHOD FOR HEMOSTASIS AT ADENOMECTOMY | 1999 |
|
RU2205604C2 |
Authors
Dates
2018-06-15—Published
2016-08-30—Filed